Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Valuation Allowance in CNY from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was ¥535M, a 22.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 535M +98.5M +22.6% Dec 31, 2023 20-F 2024-04-29
Q4 2022 437M +173M +65.3% Dec 31, 2022 20-F 2024-04-29
Q4 2021 264M +93.9M +55.1% Dec 31, 2021 20-F 2023-04-20
Q4 2020 170M +52.2M +44.2% Dec 31, 2020 20-F 2022-04-29
Q4 2019 118M Dec 31, 2019 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.